Article Information
History
- August 20, 2020.
Article Versions
- You are currently viewing Version 1 of this article (August 20, 2020 - 06:36).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Edward E. Walsh, MD1,*,
- Robert Frenck, MD2,*,
- Ann R. Falsey, MD1,
- Nicholas Kitchin, MD3,a,
- Judith Absalon, MD3,b,#,
- Alejandra Gurtman, MD3,b,
- Stephen Lockhart, DM3,a,
- Kathleen Neuzil, MD4,
- Mark J. Mulligan, MD5,
- Ruth Bailey, BSc3,a,
- Kena A. Swanson, PhD3,b,
- Ping Li, PhD3,c,
- Kenneth Koury, PhD3,b,
- Warren Kalina, PhD3,b,
- David Cooper, PhD3,b,
- Camila Fontes-Garfias, BSc6,
- Pei-Yong Shi, PhD6,
- Özlem Türeci, MD7,
- Kristin R. Tompkins, BSc3,b,
- Kirsten E. Lyke, MD4,
- Vanessa Raabe, MD5,
- Philip R. Dormitzer, MD3,b,
- Kathrin U. Jansen, PhD3,b,
- Uğur Şahin, MD7 and
- William C. Gruber, MD3,b
- 1University of Rochester and Rochester General Hospital, Rochester, NY;
- 2Cincinnati Children’s Hospital, Cincinnati, OH;
- 3Vaccine Research and Development, Pfizer Inc
- aHurley, UK,
- bPearl River, NY,
- cCollegeville, PA;
- 4University of Maryland School of Medicine, Center for Vaccine Development and Global Health, Baltimore, MD;
- 5New York University Langone Vaccine Center and New York University Grossman School of Medicine, New York, NY;
- 6University of Texas Medical Branch, Galveston, TX;
- 7BioNTech, Mainz, Germany.
- ↵#Corresponding Author: Judith Absalon, MD, MPH, FIDSA Pfizer Inc 1401 North Middletown Road Pearl River, NY 10965 Judith.absalon{at}pfizer.com
↵* Drs. Walsh and Frenck contributed equally to this article.